Skip to content

Upsher-Smith launches isotretinoin capsules

MAPLE GROVE, Minn. – Upsher-Smith announced the recent launch of isotretinoin capsules, USP in 10 mg, 20 mg, 30 mg, and 40 mg strengths.

Table of Contents

MAPLE GROVE, Minn. – Upsher-Smith announced the recent launch of isotretinoin capsules, USP in 10 mg, 20 mg, 30 mg, and 40 mg strengths. The Therapeutic Equivalence (TE) code for these Upsher-Smith products is AB1, and the original Reference Listed Drug (RLD) was the brand Accutane (isotretinoin capsules USP).

Isotretinoin Capsules, USP in 10 mg, 20 mg, 30 mg, and 40 mg strengths.
Upsher-Smith Laboratories, LLC

This product launch is part of a multi-year, multi-product collaboration between Upsher-Smith and New Zealand-based, Douglas Pharmaceuticals Ltd. (Douglas). Douglas is a leading producer of isotretinoin around the globe.

The total isotretinoin capsule market had U.S. sales of approximately $299 million for the 12 months ending April 2023 according to IQVIA.

Comments

Latest